IL-33 may promote the exacerbation of virus-induced asthma by enhancing type 2 inflammation or by attenuating innate and adaptive Th1-like and cytotoxic responses (Jackson et al., 2014; Ravanetti et al., 2019). The gene discussed is IL33; the disease is asthma.